Evidence map›Paper›PMID 32839604›Full record

ArticleNature chemical biology2020

Structural basis for antibiotic action of the B

Fabian Rabe von Pappenheim, Matteo Aldeghi, Brateen Shome, Tadhg Begley, Bert L de Groot, Kai Tittmann

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Characterization of anBiochemistry · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Low barrier hydrogen bonds in protein structure and function.Biochimica et biophysica acta. Proteins and proteomics · 2021
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Fabian Rabe von Pappenheim *Department of Molecular Enzymology, Göttingen Center of Molecular Biosciences, University of Göttingen, Göttingen, Germany.ORCID http://orcid.org/0000-0002-3925-8127
Matteo Aldeghi *Research Group of Computational Biomolecular Dynamics, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany.
Brateen ShomeDepartment of Chemistry, Texas A&M University, College Station, TX, USA.ORCID http://orcid.org/0000-0002-1981-240X
Tadhg BegleyDepartment of Chemistry, Texas A&M University, College Station, TX, USA.
Bert L de GrootResearch Group of Computational Biomolecular Dynamics, Max Planck Institute for Biophysical Chemistry, Göttingen, Germany. bgroot@gwdg.de.ORCID http://orcid.org/0000-0003-3570-3534
Kai TittmannDepartment of Molecular Enzymology, Göttingen Center of Molecular Biosciences, University of Göttingen, Göttingen, Germany. ktittma@gwdg.de.ORCID http://orcid.org/0000-0001-7891-7108
Max Planck Institute for Biophysical Chemistry · DETexas A&M University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The natural antivitamin 2'-methoxy-thiamine (MTh) is implicated in the suppression of microbial growth. However, its mode of action and enzyme-selective inhibition mechanism have remained elusive. Intriguingly, MTh inhibits some thiamine diphosphate (ThDP) enzymes, while being coenzymatically active in others. Here we report the strong inhibition of Escherichia coli transketolase activity by MTh and unravel its mode of action and the structural basis thereof. The unique 2'-methoxy group of MTh diphosphate (MThDP) clashes with a canonical glutamate required for cofactor activation in ThDP-dependent enzymes. This glutamate is forced into a stable, anticatalytic low-barrier hydrogen bond with a neighboring glutamate, disrupting cofactor activation. Molecular dynamics simulations of transketolases and other ThDP enzymes identify active-site flexibility and the topology of the cofactor-binding locale as key determinants for enzyme-selective inhibition. Human enzymes either retain enzymatic activity with MThDP or preferentially bind authentic ThDP over MThDP, while core bacterial metabolic enzymes are inhibited, demonstrating therapeutic potential.

Indexed as

Amino Acid SequenceAnti-Bacterial AgentsCatalytic DomainCoenzymesDrug DesignEnzyme InhibitorsEscherichia coliGlutamic AcidHumansHydrogen BondingKineticsMolecular Dynamics SimulationMolecular StructureProtein BindingStructure-Activity RelationshipSubstrate SpecificityAnti-Bacterial AgentsCoenzymesEnzyme InhibitorsGlutamic AcidThiamineThiamine PyrophosphateTransketolase

Identifiers

PMID32839604
OpenAlexW3080454854

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.